Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia

NCT00856973 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

486

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia
Attention Deficit Hyperactivity Disorder

Interventions

DRUG: eszopiclone
DRUG: eszopiclone
DRUG: Placebo

Sponsor

Sumitomo Pharma America, Inc.